NewsFeed
Headlines ASRM ESHRE FIGO ACOG Fertility and Sterility PCOS
November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Natav Hendin: The Challenge of Predicting Imminent Preterm Birth and Timing Neuroprotective Treatment
Natav Hendin/LinkedIn
Nov 1, 2026, 08:00

Natav Hendin: The Challenge of Predicting Imminent Preterm Birth and Timing Neuroprotective Treatment

Natav Hendin, Medical Doctor at Beilinson, Rabin Medical Center, shared a post on LinkedIn about a paper he co-authored with colleagues published in the American Journal of Obstetrics and Gynecology (AJOG):

“Pleased to share our new publication in the American Journal of Obstetrics and Gynecology (AJOG).

Our retrospective study of 692 patients across seven hospitals highlights the challenge of predicting imminent preterm birth and timing neuroprotective treatment. These findings provide benchmarks that may inform patient counseling and decisions about repeat magnesium sulfate administration when delivery does not occur as anticipated.

Watch the 2-minute AJOG video below for the key findings.

Grateful to Moti Gulersen, Matthew J. Blitz, Burton Rochelson, Frank Chervenak, and Eran Bornstein for this collaboration.”

Proceed to the video attached to the post.

Title: Patients at risk for preterm delivery: only 1 in 4 deliver within 24 hours of initial magnesium sulfate for fetal neuroprotection

Authors: Natav Hendin, Moti Gulersen, Matthew J. Blitz, Burton Rochelson, Frank A. Chervenak, Eran Bornstein

You can read the Full Article in AJOG.

Natav Hendin: The Challenge of Predicting Imminent Preterm Birth and Timing Neuroprotective Treatment

Stay informed with the latest updates in fertility and reproductive medicine on Fertility News.

AJOG American Journal of Obstetrics and Gynecology Burton Rochelson Eran Bornstein Fertility Fertility News Frank A. Chervenak Headlines Matthew J. Blitz Moti Gulersen Natav Hendin OB-GYN reproductive health Reproductive Medicine Women’s Health
NewsFeed